Huperzine-A, which is approved for AD treatment in China, has been observed to increase secretion of NGF and BDNF [353,354], and was shown to significantly improve cognitive function of memory-impaired scopolamine-treated mice when applied inside a nanocarrier-based gel to the skin [353]. The gene discussed is NGF; the disease is Alzheimer disease.